Log in
Enquire now
Steve Jurvetson

Steve Jurvetson

American businessman

OverviewStructured DataIssuesContributors

Contents

dfj.com...on.shtml
Is a
Investor
Investor
Person
Person

Person attributes

CEO of
Future Ventures
Future Ventures
Birthdate
March 1, 1967
Birthplace
Arizona
Arizona
Educated at
Stanford University
Stanford University
Stanford Graduate School of Business
Stanford Graduate School of Business
St. Mark's School of Texas
St. Mark's School of Texas
Occupation
Investor
Investor
Businessperson
Businessperson
Invested in
Sensei Biotherapeutics
Sensei Biotherapeutics

Other attributes

Birth Name
Stephen T. Jurvetson
Blog
jurvetson.blogspot.com
Citizenship
United States
United States
Member of Board of Directors of
Cambrian Biopharma
Cambrian Biopharma
0
Nickname
Steve
Wikidata ID
Q9079904
Overview

Steve Jurvetson , born Stephen T. Jurvetson on January 3, 1967 , is an American businessperson and investor. He was born in Arizona and is a citizen of the United States.

Jurvetson received his education at St. Mark's School of Texas, Stanford University, and Stanford Graduate School of Business. He is currently the CEO of Future Ventures and a member of the board of directors at Cambrian Biopharma.

Timeline

No Timeline data yet.

Current Employer

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more people like Steve Jurvetson

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.